FDA Inspection 733293 — Central Jersey Blood Center, Inc.
The FDA completed an inspection of Central Jersey Blood Center, Inc. on Jun 16, 2011 in Shrewsbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 16, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shrewsbury, NJ (United States)